typ : |
noviny |
internetový odkaz : |
http://www.currenttherapeuticres.com/article/S0011-393X(15)00016-8/abstract |
|
výzkumné týmy : |
San Francisco - Theravance Biopharma |
Autor : |
Gu Z, Parra C, Wong A, Nguyen A, Cheung R, Catalano T. |
titul : |
Post-reconstitution Stability of Telavancin with Commonly Used Diluents and Intravenous Infusion Solutions. |
Référence : |
Current Ther Res ; 77: 105-110. 2015 |
|
Úroveň důkazu : |
|
Fyzikální stabilita : |
|
chemická stabilita : |
|
jiné metody : |
|
Komentáře : |
Produkty rozkladu kvantifikovány a identifikovány |
|
Seznamy
Telavancin hydrochloride
|
|
|
|
|
15 mg/ml |
2-8°C |
|
7 |
|
|
|
|
|
|
15 mg/ml |
20-25°C |
|
12 |
|
|
|
|
|
|
15 mg/ml |
2-8°C |
|
7 |
|
|
|
|
|
|
15 mg/ml |
20-25°C |
|
12 |
|
|
|
|
|
|
0.6 mg/ml |
2-8°C |
|
7 |
|
|
|
|
|
|
0.6 mg/ml |
20-25°C |
|
12 |
|
|
|
|
|
|
8 mg/ml |
2-8°C |
|
7 |
|
|
|
|
|
|
8 mg/ml |
20-25°C |
|
12 |
|
|
|
|
|
|
0.6 mg/ml |
2-8°C |
|
7 |
|
|
|
|
|
|
0.6 mg/ml |
20-25°C |
|
12 |
|
|
|
|
|
|
8 mg/ml |
2-8°C |
|
7 |
|
|
|
|
|
|
8 mg/ml |
20-25°C |
|
12 |
|
|
|
|
|